Search research articles
Contact Us
Filters
Showing results (121-130 of 273) with videos related to
Page
of 28
Sort By:
ACR Open Rheumatology
|
November 29, 2019
Risk of Serious Infection in Patients With Rheumatoid Arthritis Treated With Biologic Versus Nonbiologic Disease-Modifying Antirheumatic Drugs
Gulsen Ozen, Sofia Pedro, Bryant R England, et al.
Medicine and Science in Sports and Exercise
|
April 3, 2025
Physical Activity and Sedentary Behavior Differ by Sex During the First Six Months after Anterior Cruciate Ligament Reconstruction
Elizabeth Wellsandt, David Werner, Matthew Tao, et al.
Arthritis Care & Research
|
September 5, 2014
Validation of the rheumatic disease comorbidity index
Bryant R England, Harlan Sayles, Ted R Mikuls, et al.
Annals of the Rheumatic Diseases
|
November 13, 2016
Risk of diabetes mellitus associated with disease-modifying antirheumatic drugs and statins in rheumatoid arthritis
Gulsen Ozen, Sofia Pedro, Marie E Holmqvist, et al.
Seminars in Arthritis and Rheumatism
|
June 13, 2026
Evaluation of physical function in patients with inflammatory myopathies using the health assessment questionnaire-II (HAQ-II)
Sung-Ki Lee, Kristin Wipfler, Ethan Ritz, et al.
Arthritis Research & Therapy
|
November 21, 2013
Rheumatoid arthritis patients are not at increased risk for 30-day cardiovascular events, infections, or mortality after total joint arthroplasty
Kaleb Michaud, Edward V Fehringer, Kevin Garvin, et al.
Arthritis Care & Research
|
February 12, 2016
Increasing Public Health Burden of Arthritis and Other Rheumatic Conditions and Comorbidity: Results From a Statewide Health Surveillance System, 2007-2012
Guang-Ming Han, Kaleb Michaud, Fang Yu, et al.
Clinicoeconomics and Outcomes Research : CEOR
|
February 22, 2019
Sarilumab monotherapy compared with adalimumab monotherapy for the treatment of moderately to severely active rheumatoid arthritis: an analysis of incremental cost per effectively treated patient
Marie Fournier, Chieh-I Chen, Andreas Kuznik, et al.
RMD Open
|
June 28, 2019
Serious infection risk in rheumatoid arthritis compared with non-inflammatory rheumatic and musculoskeletal diseases: a US national cohort study
Bella Mehta, Sofia Pedro, Gulsen Ozen, et al.
RMD Open
|
December 3, 2015
Discontinuation rates of biologics in patients with rheumatoid arthritis: are TNF inhibitors different from non-TNF inhibitors?
Sofia Ramiro, Robert Landewé, Désirée van der Heijde, et al.
Page
of 28
Search research articles
Search
Showing results (121-130 of 273) with videos related to
Sort By:
Page
of 28
ACR Open Rheumatology
|
November 29, 2019
Risk of Serious Infection in Patients With Rheumatoid Arthritis Treated With Biologic Versus Nonbiologic Disease-Modifying Antirheumatic Drugs
Gulsen Ozen, Sofia Pedro, Bryant R England, et al.
Medicine and Science in Sports and Exercise
|
April 3, 2025
Physical Activity and Sedentary Behavior Differ by Sex During the First Six Months after Anterior Cruciate Ligament Reconstruction
Elizabeth Wellsandt, David Werner, Matthew Tao, et al.
Arthritis Care & Research
|
September 5, 2014
Validation of the rheumatic disease comorbidity index
Bryant R England, Harlan Sayles, Ted R Mikuls, et al.
Annals of the Rheumatic Diseases
|
November 13, 2016
Risk of diabetes mellitus associated with disease-modifying antirheumatic drugs and statins in rheumatoid arthritis
Gulsen Ozen, Sofia Pedro, Marie E Holmqvist, et al.
Seminars in Arthritis and Rheumatism
|
June 13, 2026
Evaluation of physical function in patients with inflammatory myopathies using the health assessment questionnaire-II (HAQ-II)
Sung-Ki Lee, Kristin Wipfler, Ethan Ritz, et al.
Arthritis Research & Therapy
|
November 21, 2013
Rheumatoid arthritis patients are not at increased risk for 30-day cardiovascular events, infections, or mortality after total joint arthroplasty
Kaleb Michaud, Edward V Fehringer, Kevin Garvin, et al.
Arthritis Care & Research
|
February 12, 2016
Increasing Public Health Burden of Arthritis and Other Rheumatic Conditions and Comorbidity: Results From a Statewide Health Surveillance System, 2007-2012
Guang-Ming Han, Kaleb Michaud, Fang Yu, et al.
Clinicoeconomics and Outcomes Research : CEOR
|
February 22, 2019
Sarilumab monotherapy compared with adalimumab monotherapy for the treatment of moderately to severely active rheumatoid arthritis: an analysis of incremental cost per effectively treated patient
Marie Fournier, Chieh-I Chen, Andreas Kuznik, et al.
RMD Open
|
June 28, 2019
Serious infection risk in rheumatoid arthritis compared with non-inflammatory rheumatic and musculoskeletal diseases: a US national cohort study
Bella Mehta, Sofia Pedro, Gulsen Ozen, et al.
RMD Open
|
December 3, 2015
Discontinuation rates of biologics in patients with rheumatoid arthritis: are TNF inhibitors different from non-TNF inhibitors?
Sofia Ramiro, Robert Landewé, Désirée van der Heijde, et al.
Page
of 28